-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Reiterates Buy on DexCom, Lowers Price Target to $80

Benzinga·02/17/2026 15:52:22
Listen to the news
Truist Securities analyst Richard Newitter reiterates DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $82 to $80.